Received by email:

File: MedX Press Release April 12, 2013.pdf

                                                                            Press Release

For Immediate Release

                                    MEDX HEALTH CORP.
                                            NEWS RELEASE

TSX Venture Symbol: MDX                                               CUSIP #: 585090

April 12, 2013

For Immediate Release

 MedX announces anticipated delay in Annual Financial Results for the year ended December
                                        31, 2012

Mississauga, Ontario.- MedX Health Corp. ("MedX" or the "Company") (TSX-V: MDX). As a result of
delays in being able to obtain funding to secure fees due to its auditors, which funding has now been
secured, the Company anticipates that it will be unable to meet its originally scheduled filing of the
annual audited consolidated financial statements for the year ended December 31, 2012, the
Management's Discussion and Analysis for the for the year and relevant CEO and CFO Certifications
within the time prescribed by securities regulations, namely April 30, 2013. Management has taken
steps to resolve the difficulties, and believes that as a result it will be able to file the annual audited
consolidated financial statements, MD&A and CEO and CFO Certifications for the year ended
December 31, 2012, by May 17, 2013.

The Company has made an application to the Ontario Securities Commission, as its Principal
Regulator, for issuance of a Management Cease Trade Order pursuant to National Policy 12-203,
and intends to comply with its obligations to satisfy the provisions of the alternative information
guidelines as set out in National Policy 12-203 for so long as it remains in default

MedX is not the subject of any insolvency proceeding.

There is no other material information that has not been generally disclosed.

About MedX Health Corp.

MedX is a global leader in the development, manufacture and distribution of leading edge quality
patented optical biopsy technology used in early diagnosis of skin cancer and low level laser light
technology for use in numerous medical settings for tissue repair including rehab/sports medicine,
dentistry, wound care, and pain management.

This news release may contain assumptions, estimates, and other forward-looking statements
regarding future events. Such forward-looking statements involve inherent risks and uncertainties and
are subject to factors, many of which are beyond the Company's control that may cause actual results
or performance to differ materially from those currently anticipated in such statements.

For further information, please contact Steve Guillen, Chief Executive Officer at (905) 670-4428 Email
inquiries should be made to: Steve.Guillen@medxhealth.com and the company website is located at




                                                  Page 1
                                                                                             Press Release

www.medxhealth.com. Inquiries by direct mail should be addressed to; MedX Health Corp. 220
Superior Blvd., Mississauga, Ontario, L5T 2L2

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of
the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Certain information set out in this News Release constitutes forward-looking information. Forward-looking statements (
--->often,
but not always, identified by the use of words such as "expect", "may", "could", "anticipate" or "will" and similar ex
--->pressions)
may describe expectations, opinions or guidance that are not statements of fact and which may be based upon informatio
--->n
provided by third parties. Forward-looking statements are based upon the opinions, expectations and estimates of
management of MDX as at the date the statements are made and are subject to a variety of known and unknown risks and
uncertainties and other factors that could cause actual events or outcomes to differ materially from those anticipated
---> or
implied by such forward-looking statements. Although MDX believes that the expectations reflected in the forward-looki
--->ng
statements set out in this press release or incorporated herein by reference are reasonable, it can give no assurance 
--->that
such expectations will prove to have been correct. The forward-looking statements of MDX contained in this News Releas
--->e,
or incorporated herein by reference, are expressly qualified, in their entirety, by this cautionary statement and the 
--->risk
factors contained in MDX's current annual information form available at www.sedar.com




                                                            Page 2